Usana Health Sciences Inc (NYSE:USNA) Institutional Investors Quarterly Sentiment

USANA Health Sciences, Inc. (NYSE:USNA) Logo

Sentiment for Usana Health Sciences Inc (NYSE:USNA)

Usana Health Sciences Inc (NYSE:USNA) institutional sentiment increased to 1.35 in 2019 Q1. Its up 0.57, from 0.78 in 2018Q4. The ratio is better, as 96 investment managers increased or opened new holdings, while 71 sold and decreased their stock positions in Usana Health Sciences Inc. The investment managers in our partner’s database now possess: 13.39 million shares, up from 11.72 million shares in 2018Q4. Also, the number of investment managers holding Usana Health Sciences Inc in their top 10 holdings decreased from 2 to 0 for a decrease of 2. Sold All: 26 Reduced: 45 Increased: 56 New Position: 40.

USANA Health Sciences, Inc. develops, makes, and sells science nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company has market cap of $1.52 billion. The firm offers USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It has a 14.48 P/E ratio. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups.

The stock decreased 2.73% or $1.83 during the last trading session, reaching $65.22. About 152,593 shares traded. USANA Health Sciences, Inc. (NYSE:USNA) has declined 48.43% since August 15, 2018 and is downtrending. It has underperformed by 48.43% the S&P500.

Matarin Capital Management Llc holds 0.85% of its portfolio in USANA Health Sciences, Inc. for 138,968 shares. Bogle Investment Management L P De owns 86,996 shares or 0.56% of their US portfolio. Moreover, First Quadrant L P Ca has 0.32% invested in the company for 49,318 shares. The Massachusetts-based Acadian Asset Management Llc has invested 0.3% in the stock. Merian Global Investors (Uk) Ltd, a United Kingdom-based fund reported 363,410 shares.

More notable recent USANA Health Sciences, Inc. (NYSE:USNA) news were published by: Businesswire.com which released: “USANA Health Sciences Reports Record Results for Second Quarter 2018; Increases 2018 Outlook – Business Wire” on July 24, 2018, also Prnewswire.com with their article: “USANA signs Official Supplement Supplier license with the Korean Basketball League – PRNewswire” published on July 18, 2019, Cnbc.com published: “Sen. John McCain to be laid to rest at the US Naval Academy after a week of memorial services – CNBC” on August 27, 2018. More interesting news about USANA Health Sciences, Inc. (NYSE:USNA) were released by: Seekingalpha.com and their article: “The Real USANA Revealed – Seeking Alpha” published on August 01, 2017 as well as Finance.Yahoo.com‘s news article titled: “Have Insiders Been Selling USANA Health Sciences, Inc. (NYSE:USNA) Shares This Year? – Yahoo Finance” with publication date: June 01, 2019.

USANA Health Sciences, Inc. (NYSE:USNA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.